GlassScriptPhysician profile
Hayley Devona Chapman
NPI 1649934951
$2,008.02
in general payments reported to CMS, 2019-2025
29 companies · $845 in 2025
The $845 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $426 · 2024: $737 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,936 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,936.02 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $427.01 | 2023-2025 | |
| Ucb, INC. | $320.15 | 2024-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $212.22 | 2024-2025 | |
| Lilly USA, LLC | $101.02 | 2023-2025 | Jardiance, Zepbound, Ebglyss |
| Janssen Biotech, INC. | $98.39 | 2025 | Tremfya |
| Novo Nordisk INC | $91.39 | 2023-2024 | Rybelsus, Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $75.52 | 2023-2024 | Breztri, Farxiga |
| Organon LLC | $67.07 | 2023-2025 | Nexplanon, Hadlima |
| Pfizer INC. | $63.81 | 2023-2024 | |
| Almirall LLC | $55.71 | 2025 | Seysara |
| Leo Pharma INC. | $53.65 | 2025 | Adbry |
| Dynavax Technologies Corporation | $47.52 | 2023-2024 | Heplisav-B |
| Galderma Laboratories, L.P. | $47.32 | 2025 | Nemluvio, Aklief |
| Viiv Healthcare Company | $41.66 | 2024 | Apretude |
| Sun Pharmaceutical Industries INC. | $39.70 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $34.11 | 2023 | Doc Band |
| Janssen Pharmaceuticals, INC | $21.79 | 2023 | Spravato |
| Inspire Medical Systems, INC. | $21.67 | 2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $21.08 | 2025 | Dupixent |
| Amgen INC. | $19.05 | 2024 | Repatha |
| Harmony Biosciences LLC | $19.02 | 2024 | |
| Mayne Pharma Commercial LLC | $18.60 | 2023 | |
| Treace Medical Concepts, INC. | $18.59 | 2024 | |
| Tris Pharma INC | $17.53 | 2023 | Dyanavel Xr |
| Idorsia Pharmaceuticals US INC | $16.97 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $15.39 | 2024 | Gardasil 9, Gardasil, M-M-R II |
| Exact Sciences Corporation | $14.37 | 2023 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $14.10 | 2023 | Qelbree |
| Incyte Corporation | $13.61 | 2024 | Opzelura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hayley Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.